Dyne Therapeutics’ $374.3 Million Common Stock Offering

Wilmer Cutler Pickering Hale and Dorr advised Dyne Therapeutics, Inc. on the offering, and Cooley advised the underwriters.Dyne Therapeutics, Inc. (Nasdaq:DYN) announced the closing of its…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here